Ignite Creation Date:
2025-12-26 @ 1:19 PM
Ignite Modification Date:
2026-02-25 @ 8:50 PM
Study NCT ID:
NCT02568306
Status:
COMPLETED
Last Update Posted:
2018-07-13
First Post:
2015-10-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy Subjects
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-05
Start Date Type:
ACTUAL
Primary Completion Date:
2017-02-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02-07
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-02
First Submit QC Date:
None
Study First Post Date:
2015-10-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-12
Last Update Post Date:
2018-07-13
Last Update Post Date Type:
ACTUAL